Galmed Pharmaceuticals
GLMD
GLMD
13 hedge funds and large institutions have $80.4K invested in Galmed Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VF
Virtu Financial
New York
|
+$16K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$15.9K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$8.09K |
| 2 |
Morgan Stanley
New York
|
-$7.41K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
-$297 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$188 |
| 5 |
Wells Fargo
San Francisco,
California
|
-$13 |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
SSA
1
Schonfeld Strategic Advisors
New York
| $36.3K | -$297 | -206 | -0.8% |
|
|
VF
2
Virtu Financial
New York
| $16K | +$16K | +11,126 | New |
|
|
TSS
3
Two Sigma Securities
New York
| $15.9K | +$15.9K | +11,019 | New |
|
|
4
Morgan Stanley
New York
| $10.6K | -$7.41K | -5,145 | -41% |
|
|
5
UBS Group
Zurich,
Switzerland
| $1.59K | -$8.09K | -5,617 | -84% |
|
|
SS
6
SBI Securities
Tokyo,
Japan
| $23 | – | – | – |
|
|
FDCDDQ
7
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $20 | – | – | – |
|
|
8
Wells Fargo
San Francisco,
California
| $13 | -$13 | -9 | -50% |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $7 | – | – | – |
|
|
AF
10
Allworth Financial
Folsom,
California
| $4 | – | – | – |
|
|
EWP
11
Elevation Wealth Partners
Santa Rosa,
California
| $2 | – | – | – |
|
|
DWM
12
Dogwood Wealth Management
Lenexa,
Kansas
| $1 | – | – | – |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| – | -$188 | -59 | Closed |
|